Mosaic ImmunoEngineering Inc. SEC filings CPMV

Mosaic ImmunoEngineering Inc. has 553 filings in SEC EDGAR's recent list, going back to Dec 11, 1995. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jan 2, 2025 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
10-Q Quarterly report May 20, 2026 Mar 31, 2026
NT 10-Q 10-q extension for march 2026 May 15, 2026 Mar 31, 2026
10-K Annual report Apr 15, 2026 Dec 31, 2025
NT 10-K Notice of late filing Mar 31, 2026 Dec 31, 2025
10-Q Quarterly report Nov 19, 2025 Sep 30, 2025
NT 10-Q Extension Nov 12, 2025 Sep 30, 2025
10-Q Quarterly report Aug 19, 2025 Jun 30, 2025
NT 10-Q Extension Aug 12, 2025 Jun 30, 2025
10-Q Quarterly report May 20, 2025 Mar 31, 2025
NT 10-Q Extension May 15, 2025 Mar 31, 2025
10-K Annual report Apr 15, 2025 Dec 31, 2024
NT 10-K Extension for 10-k 2024 Mar 28, 2025 Dec 31, 2024
8-K Current report
Other events
 Jan 2, 2025 Dec 31, 2024
10-Q Quarterly report Nov 19, 2024 Sep 30, 2024
NT 10-Q 10-q extension Nov 13, 2024 Sep 30, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Officer or director change
 Jul 25, 2024 Jul 23, 2024
8-K Current report
Officer or director change
 May 31, 2024 May 31, 2024
8-K Current report
Auditor change
 May 21, 2024 May 21, 2024
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Regulation FD disclosure, Other events
 Apr 29, 2024 Apr 26, 2024
8-K Current report
Officer or director change
 Apr 19, 2024 Apr 17, 2024
10-K Annual report Apr 15, 2024 Dec 31, 2023
NT 10-K 10-k extension Mar 28, 2024 Dec 31, 2023
8-K Current report
Material agreement, Agreement ended
 Mar 28, 2024 Mar 22, 2024
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
10-Q Quarterly report Aug 3, 2023 Jun 30, 2023
8-K Current report
Material agreement, Other events
 Jun 26, 2023 Jun 21, 2023
10-Q Quarterly report May 12, 2023 Mar 31, 2023
8-K Current report
Officer or director change
 May 3, 2023 May 2, 2023
10-K Annual report Mar 2, 2023 Dec 31, 2022
RW Form rw Dec 28, 2022 —
10-Q Quarterly report Nov 1, 2022 Sep 30, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Material agreement
 Jul 12, 2022 Jul 6, 2022
10-Q Quarterly report May 10, 2022 Mar 31, 2022
8-K Current report
Material agreement, Regulation FD disclosure
 May 5, 2022 May 4, 2022
4 Insider transaction Feb 22, 2022 Feb 18, 2022
4 Insider transaction Feb 22, 2022 Feb 18, 2022
4 Insider transaction Feb 22, 2022 Feb 18, 2022
4 Insider transaction Feb 22, 2022 Feb 18, 2022
4 Insider transaction Feb 22, 2022 Feb 18, 2022
8-K Current report
Material agreement, New debt, Unregistered share sale, Change to shareholder rights
 Feb 22, 2022 Feb 18, 2022
S-1 Registration statement Feb 4, 2022 —
10-K Annual report Jan 26, 2022 Dec 31, 2021
10-Q Quarterly report Nov 2, 2021 Sep 30, 2021
10-Q Quarterly report Aug 3, 2021 Jun 30, 2021
3 Initial insider ownership Jul 16, 2021 Jul 15, 2021
DEF 14C Information statement Jun 25, 2021 Jun 25, 2021
8-K Current report
Officer or director change, Shareholder vote results, Other events
 Jun 15, 2021 Jun 14, 2021
PRE 14C Preliminary information statement Jun 15, 2021 Jun 30, 2021
4 Insider transaction May 10, 2021 May 7, 2021
4 Insider transaction May 10, 2021 May 7, 2021
8-K Current report
Material agreement, Unregistered share sale
 May 10, 2021 May 7, 2021
10-Q Quarterly report May 5, 2021 Mar 31, 2021
4 Insider transaction Apr 30, 2021 Apr 29, 2021
S-8 Employee stock plan registration Mar 9, 2021 —
10-KT Transition report Mar 2, 2021 Dec 31, 2020
EFFECT Filing Jan 29, 2021 —
4 Insider transaction Jan 29, 2021 Jan 29, 2021
4 Insider transaction Jan 29, 2021 Jan 29, 2021
4 Insider transaction Jan 29, 2021 Jan 29, 2021
4 Insider transaction Jan 29, 2021 Jan 29, 2021
CORRESP Letter to the SEC Jan 25, 2021 —
S-3/A Amendment no. 1 to form s-3 registration statement Jan 21, 2021 —
CORRESP Letter to the SEC Jan 21, 2021 —
8-K Current report
Bylaw or fiscal year change
 Dec 30, 2020 Dec 30, 2020
10-Q Quarterly report Dec 29, 2020 Nov 30, 2020
UPLOAD Letter from the SEC Dec 21, 2020 —
4 Insider transaction Dec 18, 2020 Dec 16, 2020
4 Insider transaction Dec 16, 2020 Dec 16, 2020
4 Insider transaction Dec 16, 2020 Dec 16, 2020
4 Insider transaction Dec 16, 2020 Dec 16, 2020
4 Insider transaction Dec 16, 2020 Dec 16, 2020
S-3 Shelf registration Dec 10, 2020 —
SC 13D Ownership over 5% (active) Dec 8, 2020 —
3 Initial insider ownership Dec 8, 2020 Nov 30, 2020
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
 Dec 1, 2020 Nov 30, 2020
8-K/A Amended current report
Officer or director change
 Nov 19, 2020 Aug 19, 2020
DEF 14C Information statement Nov 2, 2020 Oct 27, 2020
PRE 14C Preliminary information statement Oct 23, 2020 Oct 27, 2020
10-Q Quarterly report Oct 15, 2020 Aug 31, 2020
8-K/A Amended current report Oct 14, 2020 Aug 19, 2020
3 Initial insider ownership Aug 31, 2020 Aug 21, 2020
3 Initial insider ownership Aug 31, 2020 Aug 21, 2020
3 Initial insider ownership Aug 31, 2020 Aug 21, 2020
3 Initial insider ownership Aug 31, 2020 Aug 21, 2020
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
 Aug 25, 2020 Aug 19, 2020
10-K Annual report Aug 24, 2020 May 31, 2020
10-Q Quarterly report Apr 8, 2020 Feb 29, 2020
10-Q Quarterly report Jan 14, 2020 Nov 30, 2019
10-Q Quarterly report Oct 11, 2019 Aug 31, 2019
8-K Current report
Officer or director change
 Oct 4, 2019 Oct 1, 2019
10-K Annual report Aug 29, 2019 May 31, 2019
10-Q Quarterly report Apr 15, 2019 Feb 28, 2019
8-K Current report
Material agreement
 Apr 15, 2019 Apr 12, 2019
8-K Current report
Officer or director change
 Apr 5, 2019 Apr 1, 2019
10-Q Quarterly report Jan 14, 2019 Nov 30, 2018
10-Q Quarterly report Oct 15, 2018 Aug 31, 2018
10-K Annual report Aug 29, 2018 May 31, 2018
8-K Current report
Shareholder vote results
 Jun 5, 2018 Jun 1, 2018
DEFA14A Additional proxy material Apr 18, 2018 —
DEF 14A Proxy statement Apr 18, 2018 Apr 18, 2018
10-Q Quarterly report Apr 16, 2018 Feb 28, 2018
10-Q Quarterly report Jan 16, 2018 Nov 30, 2017
10-Q Quarterly report Oct 16, 2017 Aug 31, 2017
10-K Annual report Aug 29, 2017 May 31, 2017
8-K Current report
Shareholder vote results
 May 4, 2017 May 4, 2017
10-Q Quarterly report Apr 13, 2017 Feb 28, 2017
DEF 14A Proxy statement Mar 15, 2017 May 4, 2017
10-Q Quarterly report Jan 17, 2017 Nov 30, 2016
8-K Current report
Officer or director change
 Jan 6, 2017 Dec 30, 2016
10-Q Quarterly report Oct 17, 2016 Aug 31, 2016
CT ORDER Filing Sep 26, 2016 —
10-K Annual report Aug 29, 2016 May 31, 2016
8-K Current report
Material agreement
 Aug 16, 2016 Aug 10, 2016
8-K Current report
Shareholder vote results
 May 4, 2016 Apr 28, 2016
10-Q Quarterly report Apr 14, 2016 Feb 29, 2016
DEF 14A Proxy statement Mar 18, 2016 Apr 28, 2016
PRE 14A Preliminary proxy statement Mar 8, 2016 Apr 28, 2016
10-Q Quarterly report Jan 14, 2016 Nov 30, 2015
10-Q Quarterly report Oct 15, 2015 Aug 31, 2015
10-K Annual report Aug 31, 2015 May 31, 2015
8-K Current report
Agreement ended
 May 21, 2015 May 15, 2015
4 Insider transaction May 6, 2015 May 4, 2015
4 Insider transaction May 6, 2015 May 4, 2015
4 Insider transaction May 6, 2015 May 4, 2015
8-K Current report
Shareholder vote results
 May 4, 2015 Apr 30, 2015
8-K Current report
Other events
 Apr 20, 2015 Apr 14, 2015
10-Q Quarterly report Apr 14, 2015 Feb 28, 2015
DEF 14A Proxy statement Mar 9, 2015 Apr 30, 2015
10-Q Quarterly report Jan 14, 2015 Nov 30, 2014
CT ORDER Filing Jan 5, 2015 —
8-K Current report
Material agreement
 Oct 16, 2014 Oct 10, 2014
10-Q Quarterly report Oct 15, 2014 Aug 31, 2014
CT ORDER Filing Sep 16, 2014 —
10-K Annual report Aug 19, 2014 May 31, 2014
8-K Current report Jul 30, 2014 Jul 24, 2014
8-K Current report
Shareholder vote results
 May 1, 2014 Apr 30, 2014
10-Q Quarterly report Apr 14, 2014 Feb 28, 2014
DEF 14A Proxy statement Mar 11, 2014 Apr 30, 2014
10-Q Quarterly report Jan 14, 2014 Nov 30, 2013
10-Q Quarterly report Oct 15, 2013 Aug 31, 2013
10-K Annual report Aug 23, 2013 May 31, 2013
4 Insider transaction Jun 6, 2013 Jun 4, 2013
4 Insider transaction Jun 6, 2013 Jun 4, 2013
4 Insider transaction Jun 6, 2013 Jun 4, 2013
8-K/A Amended current report
Shareholder vote results, Regulation FD disclosure
 May 9, 2013 Apr 30, 2013
8-K/A Amended current report
Shareholder vote results, Regulation FD disclosure
 May 3, 2013 Apr 30, 2013
8-K Current report
Shareholder vote results, Regulation FD disclosure
 May 2, 2013 Apr 30, 2013
4 Insider transaction Apr 19, 2013 Apr 17, 2013
10-Q Quarterly report Apr 15, 2013 Feb 28, 2013
DEF 14A Proxy statement Mar 11, 2013 Apr 30, 2013
CT ORDER Filing Feb 14, 2013 —
8-K/A Amended current report
Material agreement
 Feb 4, 2013 Jul 11, 2012
10-Q Quarterly report Jan 14, 2013 Nov 30, 2012
10-Q Quarterly report Oct 15, 2012 Aug 31, 2012
10-K Annual report Aug 29, 2012 May 31, 2012
8-K Current report
Other events
 Jul 27, 2012 Jul 24, 2012
8-K Current report
Material agreement
 Jul 17, 2012 Jul 11, 2012
4 Insider transaction May 1, 2012 Apr 27, 2012
4 Insider transaction Apr 30, 2012 Apr 26, 2012
10-Q Quarterly report Apr 16, 2012 Feb 29, 2012
8-K Current report
Shareholder vote results
 Feb 14, 2012 Feb 14, 2012
10-Q Quarterly report Jan 17, 2012 Nov 30, 2011
DEF 14A Proxy statement Dec 21, 2011 Feb 10, 2012
10-Q Quarterly report Oct 17, 2011 Aug 31, 2011
8-K Current report
Other events
 Oct 7, 2011 Sep 30, 2011
10-K Annual report Aug 29, 2011 May 31, 2011
8-K Current report
Other events
 Aug 5, 2011 Aug 3, 2011
10-Q Quarterly report Apr 11, 2011 Feb 28, 2011
8-K Current report
Other events
 Jan 25, 2011 Jan 24, 2011
8-K Current report
Shareholder vote results
 Jan 25, 2011 Jan 19, 2011
10-Q Quarterly report Jan 14, 2011 Nov 30, 2010
NT 10-Q Notice of late filing Jan 10, 2011 Nov 30, 2010
DEFR14A Patriot scientific corporation Nov 30, 2010 —
DEF 14A Proxy statement Nov 30, 2010 Nov 30, 2010
8-K Current report
Results of operations
 Nov 12, 2010 Nov 9, 2010
8-K Current report
Bylaw or fiscal year change
 Nov 9, 2010 Nov 4, 2010
8-K Current report
Other events
 Oct 28, 2010 Oct 27, 2010
NO ACT Auto-generated paper document Oct 18, 2010 Sep 30, 2010
8-K Current report
Results of operations
 Oct 13, 2010 Oct 12, 2010
10-Q Quarterly report Oct 12, 2010 Aug 31, 2010
NO ACT Auto-generated paper document Sep 29, 2010 Aug 13, 2010
8-K Current report
Other events
 Sep 15, 2010 Sep 14, 2010
10-K Annual report Aug 16, 2010 May 31, 2010
8-K Current report
Regulation FD disclosure
 Aug 13, 2010 Aug 13, 2010
8-K Current report
Other events
 Jul 28, 2010 Jul 27, 2010
8-K Current report
Other events
 Jul 27, 2010 Jul 20, 2010
8-K Current report
Other events
 Jul 9, 2010 Jul 8, 2010
4 Insider transaction Jun 7, 2010 Jun 3, 2010
4 Insider transaction Jun 7, 2010 Jun 3, 2010
4 Insider transaction Jun 7, 2010 Jun 3, 2010
8-K Current report
Regulation FD disclosure
 Apr 27, 2010 Apr 26, 2010
8-K Current report
Other events
 Apr 13, 2010 Apr 12, 2010
10-Q Quarterly report Apr 9, 2010 Feb 28, 2010
8-K Current report
Other events
 Feb 2, 2010 Jan 25, 2010
D Filing Jan 26, 2010 —
8-K Current report
Results of operations
 Jan 12, 2010 Jan 11, 2010

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
CPMV (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Huntington Beach, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
836564
Former names
PATRIOT SCIENTIFIC CORP (until Nov 19, 2020)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.